Palatin Technologies, Inc. Common Stock (PTN)
0.9115
+0.0115 (1.28%)
Palatin Technologies is a biopharmaceutical company focused on the development of innovative therapies for a range of medical conditions, including sexual health disorders and other areas with unmet therapeutic needs
The company primarily works on peptide-based drug candidates, leveraging its proprietary technologies to create treatments that target specific physiological pathways. Palatin is committed to advancing its development programs through rigorous research and clinical trials, with the aim of providing effective solutions for patients and improving overall health outcomes.
Frequently Asked Questions
Is Palatin Technologies, Inc. Common Stock publicly traded?
Yes, Palatin Technologies, Inc. Common Stock is publicly traded.
What exchange does Palatin Technologies, Inc. Common Stock trade on?
Palatin Technologies, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Palatin Technologies, Inc. Common Stock?
The ticker symbol for Palatin Technologies, Inc. Common Stock is PTN on the New York Stock Exchange
What is the current price of Palatin Technologies, Inc. Common Stock?
The current price of Palatin Technologies, Inc. Common Stock is 0.9115
When was Palatin Technologies, Inc. Common Stock last traded?
The last trade of Palatin Technologies, Inc. Common Stock was at 8:00 pm EST on January 31st, 2025